| scholarly article | Q13442814 |
| P50 | author | Cynthia S Crowson | Q87215892 |
| Véronique L. Roger | Q110955107 | ||
| P2093 | author name string | Terry M Therneau | |
| Sherine E Gabriel | |||
| Hilal Maradit Kremers | |||
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study | Q30713072 | ||
| When does rheumatoid arthritis begin and why do we need to know? | Q33870197 | ||
| History of the Rochester Epidemiology Project | Q34374377 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Survival after the onset of congestive heart failure in Framingham Heart Study subjects | Q38512499 | ||
| Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience | Q40973059 | ||
| Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes. | Q43941034 | ||
| Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 | ||
| How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? | Q46732422 | ||
| An updated coronary risk profile. A statement for health professionals. | Q52461335 | ||
| The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years | Q57540261 | ||
| Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000 | Q61192532 | ||
| Rheumatoid factors antedating clinical rheumatoid arthritis | Q67794151 | ||
| Understanding the window of opportunity concept in early rheumatoid arthritis | Q73628284 | ||
| Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults | Q77367158 | ||
| Treating rheumatoid arthritis early: a window of opportunity? | Q77628772 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| P433 | issue | 8 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| cardiovascular disease | Q389735 | ||
| patient | Q181600 | ||
| population-based cohort study | Q108562148 | ||
| P304 | page(s) | 2268-2274 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study | |
| P478 | volume | 58 |
| Q36438294 | A Selective Inhibitor of Human C-reactive Protein Translation Is Efficacious In Vitro and in C-reactive Protein Transgenic Mice and Humans |
| Q64123686 | An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches |
| Q37856782 | Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. |
| Q26991828 | Angiotensin II in inflammation, immunity and rheumatoid arthritis |
| Q47325126 | Are obesity and rheumatoid arthritis interrelated? |
| Q53024523 | Arterial stiffness is not increased in patients with short duration rheumatoid arthritis and ankylosing spondylitis. |
| Q38846131 | Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes |
| Q38365624 | Atherosclerotic vascular disease in the autoimmune rheumatologic patient |
| Q55691195 | Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure? |
| Q38185646 | Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? |
| Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
| Q38568465 | Cardiovascular comorbidity in rheumatic diseases |
| Q33766283 | Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT) |
| Q92039365 | Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants |
| Q35617716 | Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study |
| Q36795979 | Cardiovascular risk factor management in patients with RA compared to matched non-RA patients |
| Q90629334 | Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study |
| Q38090373 | Cardiovascular risk in juvenile idiopathic arthritis |
| Q38813397 | Cardiovascular risk in patients with rheumatoid arthritis |
| Q26744334 | Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps |
| Q35788272 | Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study |
| Q37055056 | Cardiovascular risk score in Rheumatoid Arthritis |
| Q99617634 | Cardiovascular/stroke risk predictive calculators: a comparison between statistical and machine learning models |
| Q51227331 | Co-morbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up. |
| Q36513993 | Co-morbidity in patients with early rheumatoid arthritis - inflammation matters |
| Q40961450 | Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis |
| Q35188363 | Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis. |
| Q41728784 | Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study |
| Q39283765 | Diabetes mellitus and arthritis: is it a risk factor or comorbidity?: A systematic review and meta-analysis |
| Q33593925 | Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration |
| Q36573102 | Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study |
| Q37700177 | Effects of probiotic supplementation on lipid profile of women with rheumatoid arthritis: A randomized placebo-controlled clinical trial |
| Q37883018 | Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. |
| Q37774304 | Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality |
| Q34125171 | Excess risk of hospital admission for cardiovascular disease within the first 7 years from onset of inflammatory polyarthritis |
| Q36702061 | Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis |
| Q55172246 | Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis. |
| Q40379963 | Fragility Fractures Are Associated with an Increased Risk for Cardiovascular Events in Women and Men with Rheumatoid Arthritis: A Population-based Study |
| Q45871052 | Gender related issues in thrombosis and hemostasis |
| Q35019085 | Heart disease and rheumatoid arthritis: understanding the risks |
| Q61449138 | Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis |
| Q34614038 | Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study |
| Q37866668 | Lack of cardiovascular risk assessment in inflammatory arthritis and systemic lupus erythematosus patients at a tertiary care center |
| Q42756280 | Low Prevalence of Nodules in Rheumatoid Arthritis Patients in Kuwait: A Description and a Comparison of Patients from the Kuwait Registry for Rheumatic Diseases |
| Q100385873 | Machine learning prediction in cardiovascular diseases: a meta-analysis |
| Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
| Q36344968 | Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease |
| Q92841540 | Morbidity and mortality in patients with rheumatoid arthritis compared with an age- and sex-matched control population: A nationwide register study |
| Q89424853 | Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study |
| Q36327186 | Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? |
| Q44968720 | Nutritional profile in rheumatoid arthritis |
| Q36245756 | Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study |
| Q37801496 | Obesity in rheumatoid arthritis |
| Q52562359 | Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. |
| Q38858035 | Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases |
| Q36511541 | Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis |
| Q53502883 | Prevention of stroke in rheumatoid arthritis. |
| Q39082330 | Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada. |
| Q50616014 | Psychiatric and cardiovascular comorbidities as causes of long-term work disability among individuals with recent-onset rheumatoid arthritis. |
| Q51581221 | Repeat revascularisation outcomes after percutaneous coronary intervention in patients with rheumatoid arthritis. |
| Q48008568 | Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations |
| Q35126137 | Retinol binding protein 4 concentrations relate to enhanced atherosclerosis in obese patients with rheumatoid arthritis |
| Q35957651 | Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England |
| Q36001551 | Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative |
| Q36812587 | Rheumatoid arthritis and cardiovascular disease: an update on treatment issues |
| Q38648390 | Risk of Obstructive Sleep Apnea and Its Association with Cardiovascular and Noncardiac Vascular Risk in Patients with Rheumatoid Arthritis: A Population-based Study |
| Q33714074 | Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study. |
| Q47574484 | Stroke among Rheumatoid Arthritis Patients: Does Age Matter A Real-Life Study |
| Q36716845 | Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis |
| Q36907729 | Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis |
| Q37765620 | Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis |
| Q38519523 | Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis. |
| Q47878182 | Ten-year progression of coronary artery, carotid artery, and aortic calcification in patients with rheumatoid arthritis. |
| Q37323846 | The Heart and Medicine: Exploring the Interconnectedness of Cardiometabolic-related Concerns Through a Systems Biology Approach |
| Q37027093 | The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases |
| Q44558171 | The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis |
| Q34153010 | The delivery of evidence-based preventive care for older Americans with arthritis |
| Q39078542 | The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis |
| Q35092457 | The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. |
| Q35904678 | The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease |
| Q37859678 | Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis |
| Q46286636 | Total cholesterol, lipoprotein, and triglyceride levels in tumor necrosis factor inhibitor-treated patients with psoriasis, psoriatic arthritis, or rheumatoid arthritis. |
| Q44293608 | Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis |
| Q33871929 | Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. |
Search more.